<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This article reports the case of a high-functioning patient who had an "event" diagnosed as probable <z:hpo ids='HP_0010534'>transient global amnesia</z:hpo> (<z:mp ids='MP_0004110'>TGA</z:mp>) 1 year before being diagnosed with evolving <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Formal psychometric testing was necessary to make this diagnosis owing to the insensitivity of simple tests in this high-functioning individual </plain></SENT>
<SENT sid="2" pm="."><plain>Neuropsychological evaluation showed impairment of short-term verbal memory, compounded by observed fluctuations in attention </plain></SENT>
<SENT sid="3" pm="."><plain>In light of its reported benefits for cognitive function and attention, galantamine was administered starting at 4 mg b.i.d., then increasing to 8 mg b.i.d. and finally to 12 mg b.i.d </plain></SENT>
<SENT sid="4" pm="."><plain>During galantamine dose escalation, the patient experienced transient <z:hpo ids='HP_0002013'>vomiting</z:hpo> on the first day of taking 12 mg b.i.d </plain></SENT>
<SENT sid="5" pm="."><plain>With reassurance, he returned to the same dose and tolerated it during long-term treatment without problems </plain></SENT>
<SENT sid="6" pm="."><plain>His cognitive function has remained at an improved level for 18 months on galantamine administration </plain></SENT>
</text></document>